Certified by Founder Lodge
AAVantgarde Bio
Italy - Milan, Lombardy
START UP
1 Disclosed Funding Rounds $65,333,745
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Delivering the next generation gene therapies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| June, 07 ,2023 | Series A | $65,333,745 | |
| November, 07 ,2025 | Series B | $141,000,000.00 |
Atlas Venture
Sofinnova Partners
Forbion
Longwood Fund
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)
